Skip to content

Supplier News

AWS teams with Amgen on generative AI solutions

AWS teams with Amgen on generative AI solutions

Amazon Web Services (AWS) announced that Amgen is expanding its work with AWS to create generative artificial intelligence (generative AI)-based solutions to help discover, develop, and increase the manufacturing throughput of medicines for patients suffering from serious illnesses.

Camber launches generic Pepcid

Camber launches generic Pepcid

PISCATAWAY, N.J.– Camber Pharmaceuticals announced the addition of famotidine powder for oral suspension, USP to its current portfolio. Famotidine powder for oral suspension, USP is indicated: In adults for the treatment of: active duodenal ulcer (DU). active gastric ulcer (GU).

Merck to acquire Caraway Therapeutic

Merck to acquire Caraway Therapeutic

Merck and Caraway Therapeutics announced Tuesday that the companies have entered into a definitive agreement under which Merck, through a subsidiary, will acquire Caraway Therapeutics for a total potential consideration of up to $610 million, including an undisclosed upfront payment as well as conti

Camber launches generic Wellbutrin SR

Camber launches generic Wellbutrin SR

Camber Pharmaceuticals announced the addition of bupropion HCl ER tablets, USP (SR) to its current portfolio. Bupropion HCl ER tablets, USP (SR) are an aminoketone antidepressant, indicated for the treatment of major depressive disorder.